149 related articles for article (PubMed ID: 7540196)
21. Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients.
Bravo D; Muñoz-Cobo B; Costa E; Clari MA; Tormo N; Navarro D
Clin Vaccine Immunol; 2009 Jun; 16(6):885-8. PubMed ID: 19403783
[TBL] [Abstract][Full Text] [Related]
22. Detection of anti-Epstein-Barr virus trans-activator (ZEBRA) antibodies in sera from patients with human immunodeficiency virus.
Joab I; Triki H; de Saint Martin J; Perricaudet M; Nicolas JC
J Infect Dis; 1991 Jan; 163(1):53-6. PubMed ID: 1845809
[TBL] [Abstract][Full Text] [Related]
23. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
[TBL] [Abstract][Full Text] [Related]
24. Antibody response to Epstein-Barr virus Rta protein in patients with nasopharyngeal carcinoma: a new serologic parameter for diagnosis.
Feng P; Chan SH; Soo MY; Liu D; Guan M; Ren EC; Hu H
Cancer; 2001 Oct; 92(7):1872-80. PubMed ID: 11745260
[TBL] [Abstract][Full Text] [Related]
25. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
[TBL] [Abstract][Full Text] [Related]
26. [Screening of dominant epitopes of antigens related to antibodies in the sera of patients with nasopharyngeal carcinoma].
Zhang Y; Xiao XB; Zhang CQ; Li JL; Sun Y; Ye YZ; Feng KT
Ai Zheng; 2004 Sep; 23(9):999-1004. PubMed ID: 15363190
[TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2).
Xue X; Zhu S; Li W; Chen J; Ou Q; Zheng M; Gong W; Zhang L
Viral Immunol; 2011 Jun; 24(3):227-36. PubMed ID: 21668364
[TBL] [Abstract][Full Text] [Related]
28. Serum IgA antibodies to Epstein-Barr virus (EBV) early lytic antigens are present in primary EBV infection.
Bhaduri-McIntosh S; Landry ML; Nikiforow S; Rotenberg M; El-Guindy A; Miller G
J Infect Dis; 2007 Feb; 195(4):483-92. PubMed ID: 17230407
[TBL] [Abstract][Full Text] [Related]
29. Serum and salivary IgA antibodies against a defined epitope of the Epstein-Barr virus nuclear antigen (EBNA) are elevated in nasopharyngeal carcinoma.
Foong YT; Cheng HM; Sam CK; Dillner J; Hinderer W; Prasad U
Int J Cancer; 1990 Jun; 45(6):1061-4. PubMed ID: 1693600
[TBL] [Abstract][Full Text] [Related]
30. Anti-interleukin-10 antibodies in patients with chronic active Epstein-Barr virus infection.
Tanner JE; Diaz-Mitoma F; Rooney CM; Alfieri C
J Infect Dis; 1997 Dec; 176(6):1454-61. PubMed ID: 9395354
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus nuclear antigen 1 linear epitopes that are reactive with immunoglobulin A (IgA) or IgG in sera from nasopharyngeal carcinoma patients or from healthy donors.
Cheng HM; Foong YT; Sam CK; Prasad U; Dillner J
J Clin Microbiol; 1991 Oct; 29(10):2180-6. PubMed ID: 1719023
[TBL] [Abstract][Full Text] [Related]
32. Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome.
Sairenji T; Yamanishi K; Tachibana Y; Bertoni G; Kurata T
Intervirology; 1995; 38(5):269-73. PubMed ID: 8724857
[TBL] [Abstract][Full Text] [Related]
33. Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.
Tan LC; Mowat AG; Fazou C; Rostron T; Roskell H; Dunbar PR; Tournay C; Romagné F; Peyrat MA; Houssaint E; Bonneville M; Rickinson AB; McMichael AJ; Callan MF
Arthritis Res; 2000; 2(2):154-64. PubMed ID: 11062606
[TBL] [Abstract][Full Text] [Related]
34. Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray.
Loebel M; Eckey M; Sotzny F; Hahn E; Bauer S; Grabowski P; Zerweck J; Holenya P; Hanitsch LG; Wittke K; Borchmann P; Rüffer JU; Hiepe F; Ruprecht K; Behrends U; Meindl C; Volk HD; Reimer U; Scheibenbogen C
PLoS One; 2017; 12(6):e0179124. PubMed ID: 28604802
[TBL] [Abstract][Full Text] [Related]
35. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
[TBL] [Abstract][Full Text] [Related]
36. Humoral immune response in Epstein-Barr virus infections. I. Elevated serum concentration of the IgG1 subclass in infectious mononucleosis and nasopharyngeal carcinoma.
Kaschka WP; Hilgers R; Skvaril F
Clin Exp Immunol; 1982 Jul; 49(1):149-56. PubMed ID: 6290114
[TBL] [Abstract][Full Text] [Related]
37. Serological diagnosis of nasopharyngeal carcinoma by enzyme linked immunosorbent assay: optimization, standardization and diagnostic criteria.
Ng MH; Chen HL; Luo RX; Chan KH; Woo PC; Sham JS; Huang J; Seto WH; Smith P; Griffin BE
Chin Med J (Engl); 1998 Jun; 111(6):531-6. PubMed ID: 11245074
[TBL] [Abstract][Full Text] [Related]
38. Frequency of Epstein-Barr virus-specific cytotoxic T lymphocytes in the blood of Southern Chinese blood donors and nasopharyngeal carcinoma patients.
Whitney BM; Chan AT; Rickinson AB; Lee SP; Lin CK; Johnson PJ
J Med Virol; 2002 Jul; 67(3):359-63. PubMed ID: 12116028
[TBL] [Abstract][Full Text] [Related]
39. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
40. Antibody responses to defined epitopes in the Epstein-Barr virus BZLF1-encoded transactivator protein among human immunodeficiency virus-infected patients.
Tedeschi R; Dillner J; De Paoli P
Clin Diagn Lab Immunol; 1996 May; 3(3):363-4. PubMed ID: 8705686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]